Published October, 2021
By Hideyuki Saito and Takaaki Abe
Publisher: Springer (Springer Verlag, Singapore)
Rating:
in-stock

Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients.

---

Published October, 2021
By Joel D. Kopple, Shaul G. Massry, Kamyar Kalantar-Zadeh and Denis Fouque
Publisher: Elsevier (Academic Press Inc)
Rating:
in-stock

---

Published September, 2021
By Lailah Turner
Publisher: Readers First Publishing Ltd
Rating:
in-stock

---

Published September, 2021
By Laney Bender
Publisher: Readers First Publishing Ltd
Rating:
in-stock

---

Published September, 2021
By Jinghua Hu and Yong Yu
Publisher: Taylor & Francis
Rating:
in-stock

---

Published September, 2021
By Stephen Z. Fadem
Publisher: Nova Science Publishers Inc
Rating:
in-stock

---

Published September, 2021
By Isaac Teitelbaum, Larry K Golightly, Tyree H. Kiser, Gerard R. Barber, Nancy M. Stolpman, Larry K. Golightly, PharmD, Bonita A. Simendinger, PharmD, BCPS, Tyree H. Kiser, PharmD, BCPS, Gerard R. Barber, RPh, MPH, Nancy M. Stolpman, PharmD, PhD and Bonita A. Simendinger
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
in-stock

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function.

---

Published September, 2021
By Susan Davis
Publisher: Susan Davis
Rating:
in-stock

---

Published September, 2021
By Sally Smith
Publisher: Independently Published
Rating:
in-stock

---

Published September, 2021
By Stephen Z. Fadem
Publisher: Nova Science Publishers Inc
Rating:
in-stock

---